The Proteomic Profile of Hereditary Inclusion Body Myopathy
Author Information
Author(s): Sela Ilan, Milman Krentsis, Irit Shlomai, Sadeh Menachem, Dabby Ron, Argov Zohar, Ben-Bassat Hannah, Mitrani-Rosenbaum Stella
Primary Institution: Goldyne Savad Institute for Gene Therapy, Hadassah Hebrew University Medical Center, Jerusalem, Israel
Hypothesis
The goal of this study was to unravel new clues on the biological pathways leading to HIBM by proteomic comparison.
Conclusion
The study identified differentially expressed proteins in hereditary inclusion body myopathy that are mainly related to cytoskeleton and sarcomere organization.
Supporting Evidence
- 41 proteins were differentially expressed in muscle cultures from HIBM patients compared to controls.
- 26 proteins were differentially expressed in biopsies from HIBM patients compared to controls.
- 30% of the differentially expressed proteins were related to cytoskeleton and sarcomere organization.
Takeaway
Researchers looked at muscle samples from people with a rare muscle disease to find out which proteins are different in their muscles compared to healthy ones.
Methodology
Muscle cultures and biopsies were analyzed using two-dimensional gel electrophoresis (2-DE) and isobaric tag for relative and absolute quantitation (iTRAQ).
Limitations
The study did not find unique proteins present in all HIBM samples, and the expression differences were not statistically significant in some analyses.
Participant Demographics
Participants included HIBM patients, most of whom were of Jewish-Persian descent.
Statistical Information
P-Value
0.1090
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website